Clinical Trials Logo
  1. Home
  2. Severe Pre-eclampsia
  3. NCT05176652

Ultrasonographic Diameter of Optic Nerve Sheath in Fluid Assessment in Severe Preeclamptic Patients

Severe Pre-eclampsia Clinical Trial

Official title:
Reliability of Utrasonographic Diameter of Optic Nerve Sheath in Assessment of Fluid Status in Severe Preeclamptic Patients

Clinical Trial Summary

Changes in the optic nerve sheath diameter detected by ultrasound are considered an important manifestation of increased intracranial pressure . The normal optic nerve sheath diameter measures up to 5.0 mm and an average optic nerve sheath diameter more than 5 mm is considered abnormal and elevated intracranial pressure should be suspected.Cerebral edema have been demonstrated in 71% to 100% of magnetic resonance imaging in preeclamptic patients and an increase in optic nerve sheath diameter has been described in preeclamptic females compared to healthy pregnant females Therefore, Increased optic nerve sheath diameter can indirectly reflect the state of intracranial edema that could be a part of generalized edema of preeclampsia and it could be a possible marker of generalized tissue edema and fluid overload in these patients.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05176652
Study type Observational
Source Sohag University
Contact Hossam Eldin Hassan ahmed, assisstant lecturer
Phone 01000393835
Email hossamhassan01000393835@gmail.com
Status Recruiting
Phase
Start date December 6, 2021
Completion date December 6, 2022
View Details
See also
  Status Clinical Trial Phase
Completed NCT03661775 - Serum Magnesium Level Administration in Severe Pre-eclampsia Obese Pregnancy N/A
Completed NCT02164370 - Evaluation of Metabolic Acid-base Abnormalities in Pre-eclamptic Women Applying the Stewart-Fencl Approach N/A
Recruiting NCT06219109 - Pulmonary Edema Resolution in Severe Preeclampsia and Eclampsia
Not yet recruiting NCT06385600 - Intravenous Labetalol vs Phentolamine for the Management of Severe Preeclampsia. N/A
Recruiting NCT05283473 - Serum Magnesium Concentration in Magnesium Sulfate Therapy for Severe Preeclampsia
Completed NCT01766089 - Dexmedetomidine vs. Remifentanil for Pre-eclampsia During Caesarean Delivery Phase 2
Completed NCT06126068 - Comparison of Loading Dose Magnesium Sulphate With Prichard Regimen in the Management of Severe Preeclampsia and Eclampsia. N/A
Not yet recruiting NCT02314286 - Rosuvastatin in Order to Induce Preeclampsia Resolution in Severe PET up to 48 Hours Following Delivery Phase 1/Phase 2
Completed NCT05310929 - Nitroglycerin Versus Labetalol in Acute Severe Pre-eclampsia N/A